EUVIMEDEUVIMED entdecken
Crossref

Characteristics of the MicroRNA‐Processing Enzymes in Melanocytic Skin Lesions: Dicer and DGCR8 Are Potential Biomarkers for Primary Cutaneous Melanomas

Fabiola Schafer iD, Enrique Bellolio iD, Tatiana Sepúlveda, Mirta Espinoza iD, Juan-José Orellana, Isabel Bellolio, Miguel Angel Villaseca, Rodrigo Miranda

Experimental Dermatology · 2025

DOI: 10.1111/exd.70110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Fabiola Schafer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Specialties, School of Medicine, Universidad de La Frontera, Temuco, Chile. Hauptthemen laut MEDLINE: Ribonuclease III, Melanoma, Skin Neoplasms, DEAD-box RNA Helicases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Universidad de La Frontera, DIUFRO, Universidad de La Frontera.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary cutaneous melanoma (PCM) is an aggressive skin cancer. Its physiopathology is a challenge with heterogeneous pathways involved. As such, microRNA‐processing enzymes have been shown to be deregulated in cancer. The aim of this study was to characterise the expression profile of Dicer, Drosha, DGCR8 and PACT enzymes in melanocytic skin lesions. A total of 126 formalin‐fixed paraffin‐embedded samples, including 42 benign nevi, 42 dysplastic nevi and 42 PCM, were studied using tissue microarray and immunohistochemistry, which was graded based on the percentage of immunoreactive tumour cells (%IRC). Increased Dicer immunoexpression was found in PCM compared to benign nevi ( p = 0.044) and increased DGCR8 immunoexpression was found in PCM compared to dysplastic and benign nevi ( p = 0.000). For Drosha and PACT, only dysplastic nevi showed an increased expression ( p = 0.011). A ROC curve cut‐off of 80% IRC was used. For Dicer, the specificity for non‐malignant cutaneous lesions (NMCL) was 98.8%, and sensitivity for PCM was 31.0%. The negative predictive value (NPV) was 98.6% and positive predictive value (PPV) was 34.7%. For DGCR8, the specificity for NMCL was 100%, and sensitivity for PCM was 31.0%. The NPV was 98.6% and PPV was 100%. All cases with positive Dicer and DGCR8 immunoexpression were melanomas. Dicer was increased in nodular histologic subtype ( p = 0.011) and DGCR8 was higher in males ( p = 0.005). Both Dicer and DGCR8 were increased in ulcerated PCM ( p < 0.05). Dicer and DGCR8 play an important role in melanoma development with a potential use as diagnostic tools to differentiate PCM from other melanocytic skin lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ribonuclease IIIMelanomaSkin NeoplasmsDEAD-box RNA HelicasesRNA-Binding ProteinsBiomarkers, TumorHumansMaleFemaleMiddle AgedMicroRNAsAdultAgedAged, 80 and overYoung Adult

Stichwörter der Autor:innen

DGCR8dicermelanomamicroRNA‐processing enzymespathogenesis

Substanzen

Ribonuclease IIIDGCR8 protein, humanDEAD-box RNA HelicasesRNA-Binding ProteinsDICER1 protein, humanBiomarkers, TumorMicroRNAsDROSHA protein, human

Autor:innen und Institutionen

  • Department of Medical Specialties, School of Medicine, Universidad de La Frontera, Temuco, Chile.
  • Department of Pathological Anatomy, School of Medicine, Universidad de La Frontera, Temuco, Chile.
  • Department of Public Health and Capacitación, Investigación y Gestión Para la Salud Basada en Evidencias (CIGES), School of Medicine, Universidad de La Frontera, Temuco, Chile.
  • School of Medicine, Universidad de La Frontera, Temuco, Chile.
  • Department of Internal Medicine, School of Medicine, Universidad de La Frontera, Temuco, Chile.

ORCID-Profile: Fabiola Schafer, Enrique Bellolio, Mirta Espinoza

Förderung

  • Universidad de La Frontera, DIUFRO
  • Universidad de La Frontera

Zitieren

APA

Schafer, F., Bellolio, E., Sepúlveda, T., Espinoza, M., Orellana, J. J., Bellolio, I., Villaseca, M. A., & Miranda, R. (2025). Characteristics of the MicroRNA‐Processing Enzymes in Melanocytic Skin Lesions: Dicer and DGCR8 Are Potential Biomarkers for Primary Cutaneous Melanomas. Experimental Dermatology. https://doi.org/10.1111/exd.70110

Vancouver

Schafer F, Bellolio E, Sepúlveda T, Espinoza M, Orellana JJ, Bellolio I, et al. Characteristics of the MicroRNA‐Processing Enzymes in Melanocytic Skin Lesions: Dicer and DGCR8 Are Potential Biomarkers for Primary Cutaneous Melanomas. Experimental Dermatology. 2025. doi:10.1111/exd.70110

BibTeX
@article{Schafer2025,
  author = {Schafer, Fabiola and Bellolio, Enrique and Sepúlveda, Tatiana and Espinoza, Mirta and Orellana, Juan-José and Bellolio, Isabel and Villaseca, Miguel Angel and Miranda, Rodrigo},
  title = {Characteristics of the MicroRNA‐Processing Enzymes in Melanocytic Skin Lesions: Dicer and DGCR8 Are Potential Biomarkers for Primary Cutaneous Melanomas},
  journal = {Experimental Dermatology},
  year = {2025},
  doi = {10.1111/exd.70110}
}
Kostenlos starten →